149
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Pimozide and pancreatic cancer in diabetic chorea: a case report

ORCID Icon, , , , , , & show all
Pages 1217-1220 | Received 28 May 2020, Accepted 27 Dec 2020, Published online: 03 Feb 2021

References

  • Chua CB, Sun CK, Hsu CW, et al. “Diabetic striatopathy”: clinical presentations, controversy, pathogenesis, treatments, and outcomes. Sci Rep. 2020;10(1):1–12. https://doi.org/10.1038/s41598-020-58555-w.
  • Gómez-Ochoa SA, Espín-Chico BB, Pinilla-Monsalve GD, et al. Clinical and neuroimaging spectrum of hyperglycemia-associated chorea-ballism: systematic review and exploratory analysis of case reports. Funct Neurol. 2018;33:175–187. http://www.ncbi.nlm.nih.gov/pubmed/30663963.
  • Oh SH, Lee KY, Im JH, et al. Chorea associated with non-ketotic hyperglycemia and hyperintensity basal ganglia lesion on T1-weighted brain MRI studya meta-analysis of 53 cases including four present cases. J Neurol Sci. 2002;200(1-2):57–62. https://doi.org/10.1016/S0022-510X(02)00133-8.
  • Son B, Choi J, Ko H. Globus pallidus internus deep brain stimulation for disabling diabetic hemiballism/hemichorea. Case Rep Neurol Med. 2017;2017:2165905. https://doi.org/10.1155/2017/2165905.
  • Ohmori H, Hirashima K, Ishihara D, et al. Two cases of hemiballism-hemichorea with T1-weighted MR image hyperintensities in patients with hyperglycemia. Intern Med. 2005;44(12):1280–1285. https://doi.org/10.2169/internalmedicine.44.1280.
  • Broderick JP, Hagen T, Brott T, et al. Hyperglycemia and hemorrhagic transformation of cerebral infarcts. Stroke. 1995;26(3):484–487. https://doi.org/10.1161/01.STR.26.3.484.
  • D'Angelo R, Rinaldi R, Pinardi F, et al. Acute chorea-dystonia heralding diabetes mellitus. BMJ Case Rep. 2013;2013:bcr2013009221. https://doi.org/10.1136/bcr-2013-009221.
  • Yaltho TC, Schiess MC, Furr-Stimming E. Acute bilateral basal ganglia lesions and chorea in a diabetic-uremic patient on dialysis. Arch Neurol. 2010;67(2):246–247.
  • Videnovic A. Treatment of Huntington disease. Curr Treat Options Neurol. 2013;15(4):424–438. https://doi.org/10.1007/s11940-013-0219-8.
  • Walker KG, Wilmshurst JM. An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions. Ther Adv Neurol Disord. 2010;3(5):301–309. https://doi.org/10.1177/1756285610382063.
  • Karolewicz B, Antkiewicz-Michaluk L, Michaluk J, et al. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain. Eur J Pharmacol. 1996;313(3):181–186. https://doi.org/10.1016/0014-2999(96)00451-7.
  • Grabski R, Dewit J, De Braekeleer J, et al. Inhibition of T-cell invasion across cultured fibroblast monolayers by phenothiazine-related calmodulin inhibitors: impairment of lymphocyte motility by trifluoperazine and chlorpromazine, and alteration of the monolayer by pimozide. Biochem Pharmacol. 2001;61(10):1313–1317. https://doi.org/10.1016/S0006-2952(01)00585-8.
  • Zainelli GM, Ross CA, Troncoso JC, et al. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin. J Neurosci. 2004;24(8):1954–1961.
  • Kirvan CA, Swedo SE, Kurahara D, et al. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity. 2006;39(1):21–29. https://doi.org/10.1080/08916930500484757.
  • Zheng W, Chen L, Chen J, et al. Hemichorea associated with non-ketotic hyperglycemia: a case report and literature review. Front Neurol. 2020;11:96. https://doi.org/10.3389/fneur.2020.00096.
  • Klawans HL. Jr., A pharmacologic analysis of Huntington's chorea. Eur Neurol. 1970;4(3):148–163. https://doi.org/10.1159/000114017.
  • Cunningham MW, Cox CJ. Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond. Acta Physiol (Oxf). 2016;216(1):90–100. https://doi.org/10.1111/apha.12614.
  • Ryan C, Ahlskog JE, Savica R. Hyperglycemic chorea/ballism ascertained over 15 years at a referral medical center. Parkinsonism Relat Disord. 2018;48:97–100. https://doi.org/10.1016/j.parkreldis.2017.12.032.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.